GALWAY, IRELAND--January 22, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The $63 billion merger of pharmaceutical giant AbbVie (NYSE:ABBV) (Chicago, Illinois) and Ireland's Allergan plc (NYSE:AGN) (Dublin, Ireland) has taken a major step toward completion with the deal getting the "conditional" green light from the European Commission (EC).

Within this article: Details conditional EU permission, overlap in products, proposal for IBD treatment divestment and continued research

Login to Read More